Full text is available at the source.
Abstract
Preliminary evidence suggests that GLP-1 receptor agonists may be an effective adjunct therapy for hidradenitis suppurativa in patients with obesity.
- Hidradenitis suppurativa is a chronic skin condition characterized by painful nodules and abscesses.
- The condition involves immune system dysfunction, metabolic issues, and hormonal factors.
- GLP-1 receptor agonists are known for their anti-inflammatory effects and weight loss benefits.
- Three publications were identified that examined the role of GLP-1 receptor agonists in treating hidradenitis suppurativa.
- Larger controlled studies are needed to validate the efficacy and safety of GLP-1 receptor agonists for this condition.
Simplified